de la Harpe KM, Kondiah PPD, Choonara YE, Marimuthu T, du Toit LC, Pillay V
Increased Risk of Adverse Side Effects Both semaglutide and tirzepatide share common gastrointestinal side effects, including nausea, vomiting, diarrhea, and constipation
health systems and may not fully generalize to underserved or non-U.S
Liraglutide therapy significantly mitigated DPN by enhancing motor and sensory nerve conduction velocities and restoring myelin fiber density in diabetic mice [11]
In another example, a 2023 report by market research firm Circana [1] , which tracks in-store purchases using scanner data purchased from retailers, found that GLP-1 users were scaling back purchases at a similar level to the average US household, with a marginal unit sales decline of 0.1% higher. The report did note, however, that households with a GLP-1 user were purchasing different items than non-GLP-1 households namely: high-protein, energy-boosting, hydration, and convenient snack products. GLP-1 medications have several side effects, including nausea and muscle loss